↓ Skip to main content

Next generation of immune checkpoint inhibitors and beyond

Overview of attention for article published in Journal of Hematology & Oncology, March 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
4 news outlets
twitter
5 X users
patent
1 patent

Citations

dimensions_citation
332 Dimensions

Readers on

mendeley
397 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Next generation of immune checkpoint inhibitors and beyond
Published in
Journal of Hematology & Oncology, March 2021
DOI 10.1186/s13045-021-01056-8
Pubmed ID
Authors

Julian A. Marin-Acevedo, ErinMarie O. Kimbrough, Yanyan Lou

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 397 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 397 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 52 13%
Student > Master 43 11%
Researcher 40 10%
Student > Bachelor 35 9%
Student > Doctoral Student 18 5%
Other 45 11%
Unknown 164 41%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 61 15%
Immunology and Microbiology 44 11%
Medicine and Dentistry 42 11%
Pharmacology, Toxicology and Pharmaceutical Science 20 5%
Agricultural and Biological Sciences 17 4%
Other 36 9%
Unknown 177 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 38. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 March 2024.
All research outputs
#1,089,806
of 25,611,630 outputs
Outputs from Journal of Hematology & Oncology
#53
of 1,299 outputs
Outputs of similar age
#30,395
of 454,881 outputs
Outputs of similar age from Journal of Hematology & Oncology
#4
of 48 outputs
Altmetric has tracked 25,611,630 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,299 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.5. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 454,881 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 48 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.